维持型血液透析患者中代谢性酸中毒的临床研究进展

孙超

doi:10.12122/j.issn.1674-4500.2019.04.24

维持型血液透析患者中代谢性酸中毒的临床研究进展

doi: 10.12122/j.issn.1674-4500.2019.04.24

孙超

中国人民解放军南部战区总医院肾内科血透室，广东广州 510010

详细信息

作者简介:
孙超：孙超，本科，E-mail：vinsonlong@vip.163.com

计量
- 文章访问数: 1244
- HTML全文浏览量: 443
- PDF下载量: 30
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-20
- 刊出日期: 2019-12-01

Advances in clinical researches of metabolic acidosis in maintenance hemodialysis

Chao SUN

Department of Hemodialysis Division, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, China

摘要

摘要: 代谢性酸中毒是慢性肾病的常见并发症之一。病人一旦发展为终末期肾病，血清碳酸氢盐浓度会显著降低，从而加重病情。代谢性酸中毒纠正对血透患者的临床治疗和预后具有重要意义。血清碳酸氢盐浓度过低会显著加快肾脏疾病病程，浓度过高则会增加心血管疾病风险。现阶段关于血清碳酸氢盐浓度的最优临床参考值尚无定论。针对代谢性酸中毒与血透预后的研究多集中于代谢性酸中毒发展的不良后果，对于血清碳酸氢盐水平的临床纠正过程中需要考虑的影响因素少有讨论。本文主要针对维持性血液透析中代谢性酸中毒发生的影响因素、不良后果以及临床治疗需要考虑的因素展开论述，旨在通过汇总分析临床流行病学和实验室研究结论，探讨纠正血清碳酸氢盐水平的行之有效的临床方案。
- 代谢性酸中毒 /
- 血液透析 /
- 碳酸氢盐 /
- 透析液
Abstract: Metabolic acidosis (MA) is a kind of common complication of chronic kidney disease. Serum bicarbonate (HCO₃⁻) concentration would significantly decrease once the end-stage renal disease was diagnosed. It would worsen the condition. MA correction would contribute to the clinical therapy and the prognosis of maintenance hemodialysis (MHD) patients. Low concentration of HCO₃⁻ would accelerate the progression of kidney disease, and high concentration of HCO₃⁻ would pose the risk of cardiovascular disease. Nevertheless, the optimal clinical reference value of serum bicarbonate concentration is still unknown. The factors that should be considered in dialysis treatment are also complicated. This paper mainly reviews the factors of MA occurrence and adverse effects in MHD patients, and further discusses the relevant practical considerations in the clinical therapy of MA in MHD. We aim to provide theoretical references for MA treatment by analyzing the results of large cohort study around the world and that from wet-lab.
- metabolic acidosis /
- hemodialysis /
- bicarbonate /
- dialysate

HTML全文

参考文献(36)

[1]	Boron WF. Acid-base transport by the renal proximal tubule[J]. J Am Soc Nephrol, 2006, 17(9): 2368-82. doi: 10.1681/ASN.2006060620
[2]	Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review[J]. J Am Med Assoc, 2019, 322(13): 1294-304. doi: 10.1001/jama.2019.14745
[3]	Romagnani P, Remuzzi G, Glassock R, et al. Chronic kidney disease[J]. Nat Rev Dis Primers, 2017, 3(1): 7088-100.
[4]	Dobre M, Yang W, Chen J, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study[J]. Am J Kidney Dis, 2013, 62(4): 670-8. doi: 10.1053/j.ajkd.2013.01.017
[5]	Vashistha T, Kalantar-Zadeh K, Molnar MZ, et al. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality[J]. Clin J Am Soc Nephrol, 2013, 8(2): 254-64. doi: 10.2215/CJN.05780612
[6]	路香雪, 李寒, 王世相. 透析液碳酸氢盐浓度对透析患者预后的影响[J]. 中国血液净化, 2017, 16(11): 758-760.
[7]	Kraut JA, Madias NE. Consequences and therapy of the metabolic acidosis of chronic kidney disease[J]. Pediatr Nephrol, 2011, 26(1): 19-28. doi: 10.1007/s00467-010-1564-4
[8]	Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management[J]. Nat Rev Nephrol, 2010, 6(5): 274-85. doi: 10.1038/nrneph.2010.33
[9]	Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review[J]. Lancet, 2015, 385(9981): 1975-82. doi: 10.1016/S0140-6736(14)61601-9
[10]	Cohen RM, Feldman GM, Fernandez PC. The balance of acid, base and charge in health and disease[J]. Kidney Int, 1997, 52(2): 287-93. doi: 10.1038/ki.1997.334
[11]	Kraut JA, Madias NE. Metabolic acidosis of CKD: an Update[J]. Am J Kidney Dis, 2016, 67(2): 307-17. doi: 10.1053/j.ajkd.2015.08.028
[12]	Shapiro BB, Bross R, Morrison G, et al. Self-reported interview-assisted diet records underreport energy intake in maintenance hemodialysis patients[J]. J Ren Nutr, 2015, 25(4): 357-63. doi: 10.1053/j.jrn.2014.12.004
[13]	Lopes AA, Bragg-Gresham JL, Elder SJ, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS)[J]. J Ren Nutr, 2010, 20(4): 224-34. doi: 10.1053/j.jrn.2009.10.002
[14]	宋亦琪, 倪丽, 陈靖. 维持性血液透析患者营养评估及相关进展[J]. 中国血液净化, 2018, 17(1): 51-3. doi: 10.3969/j.issn.1671-4091.2018.01.012
[15]	Fouque D, Vennegoor M, Wee P, et al. EBPG guideline on nutrition[J]. Nephrol Dial Transplant, 2007, 22(Suppl 2): 45-87.
[16]	Susantitaphong P, Koulouridis I, Balk EM, et al. Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis[J]. Am J Kidney Dis, 2012, 59(5): 689-99. doi: 10.1053/j.ajkd.2011.12.020
[17]	Shafiee MA, Chamanian P, Shaker P, et al. The impact of hemodialysis frequency and duration on blood pressure management and quality of life in end-stage renal disease patients[J]. Healthcare (Basel), 2017, 5(3): 510-9.
[18]	Saha SK, Islam RN, Rahim MA, et al. Dialysis adeuacy and quality of life in diabetic and non-diabetic Bangladeshi patients on mainenance hemodialysis[J]. Birdem Med J, 2019, 9(2): 138-46. doi: 10.3329/birdem.v9i2.41280
[19]	Menon V, Tighiouart H, Vaughn NS, et al. Serum bicarbonate and long-term outcomes in CKD[J]. Am J Kidney Dis, 2010, 56(5): 907-14. doi: 10.1053/j.ajkd.2010.03.023
[20]	Chen W, Abramowitz MK. Metabolic acidosis and the progression of chronic kidney disease[J]. BMC Nephrol, 2014, 15(55): 1609-20.
[21]	Coles GA. Body composition in chronic renal failure[J]. J Med, 1972, 41(161): 25-47.
[22]	Lu KC, Lin SH, Yu FC, et al. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure[J]. Miner Electrolyte Metab, 1995, 21(6): 398-402.
[23]	Kleger GR, Turgay M, Imoberdorf R, et al. Acute metabolic acidosis decreases muscle protein synthesis but not albumin synthesis in humans[J]. Am J Kidney Dis, 2001, 38(6): 1199-207. doi: 10.1053/ajkd.2001.29215
[24]	Brungger M, Hulter HN, Krapf R. Effect of chronic metabolic acidosis on thyroid hormone homeostasis in humans[J]. Am J Physiol, 1997, 272(5 Pt 2): F648-53.
[25]	Pickering WP, Price SR, Bircher G, et al. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle[J]. Kidney Int, 2002, 61(4): 1286-92. doi: 10.1046/j.1523-1755.2002.00276.x
[26]	Domrongkitchaiporn S, Pongskul C, Sirikulchayanonta V, et al. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis[J]. Kidney Int, 2002, 62(6): 2160-6. doi: 10.1046/j.1523-1755.2002.00656.x
[27]	Kraut JA, Mishler DR, Singer FR, et al. The effects of metabolic acidosis on bone formation and bone resorption in the rat[J]. Kidney Int, 1986, 30(5): 694-700. doi: 10.1038/ki.1986.242
[28]	Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement[J]. Pediatr Nephrol, 2006, 21(7): 917-30. doi: 10.1007/s00467-006-0020-y
[29]	Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway[J]. J Clin Invest, 1996, 97(6): 1447-53. doi: 10.1172/JCI118566
[30]	Igarashi M, Yamatani K, Fukase N, et al. Effect of acidosis on insulin binding and glucose uptake in isolated rat adipocytes[J]. Tohoku J Exp Med, 1993, 169(3): 205-13. doi: 10.1620/tjem.169.205
[31]	Sonikian M, Gogusev J, Zingraff J, et al. Potential effect of metabolic acidosis on beta 2-microglobulin generation: in vivo and in vitro studies[J]. J Am Soc Nephrol, 1996, 7(2): 350-6.
[32]	Bellocq A, Suberville S, Philippe C, et al. Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages: evidence for involvement of nuclear factor-kappaB activation[J]. J Biol Chem, 1998, 273(9): 5086-92. doi: 10.1074/jbc.273.9.5086
[33]	Tentori F, Karaboyas A, Robinson BM, et al. Association of dialysate bicarbonate concentration with mortality in the dialysis outcomes and practice patterns study[J]. Am J Kidney Dis, 2013, 62(4): 738-46. doi: 10.1053/j.ajkd.2013.03.035
[34]	Yamamoto T, Shoji S, Yamakawa T, et al. Predialysis and postdialysis pH and bicarbonate and risk of all-cause and cardiovascular mortality in long-term hemodialysis patients[J]. Am J Kidney Dis, 2015, 66(3): 469-78. doi: 10.1053/j.ajkd.2015.04.014
[35]	Oettinger CW, Oliver JC. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate[J]. J Am Soc Nephrol, 1993, 3(11): 1804-7.
[36]	Coe FL, Firpo JJ, Hollandsworth DL, et al. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man[J]. Kidney Int, 1975, 8(4): 263-73.